ATE417856T1 - Motilidverbindungen - Google Patents

Motilidverbindungen

Info

Publication number
ATE417856T1
ATE417856T1 AT03755757T AT03755757T ATE417856T1 AT E417856 T1 ATE417856 T1 AT E417856T1 AT 03755757 T AT03755757 T AT 03755757T AT 03755757 T AT03755757 T AT 03755757T AT E417856 T1 ATE417856 T1 AT E417856T1
Authority
AT
Austria
Prior art keywords
sup
motilide
compounds
motilide compounds
diseases
Prior art date
Application number
AT03755757T
Other languages
English (en)
Inventor
Daniel Santi
Brian Metcalf
Christopher Carreras
Yaoquan Liu
Robert Mcdaniel
Eduardo Rodriguez
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE417856T1 publication Critical patent/ATE417856T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cephalosporin Compounds (AREA)
  • Pyrrole Compounds (AREA)
AT03755757T 2002-08-29 2003-08-26 Motilidverbindungen ATE417856T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40734502P 2002-08-29 2002-08-29

Publications (1)

Publication Number Publication Date
ATE417856T1 true ATE417856T1 (de) 2009-01-15

Family

ID=31978464

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03755757T ATE417856T1 (de) 2002-08-29 2003-08-26 Motilidverbindungen

Country Status (15)

Country Link
US (1) US6946482B2 (de)
EP (1) EP1532131B1 (de)
JP (1) JP4796300B2 (de)
KR (1) KR101051613B1 (de)
CN (1) CN100363359C (de)
AT (1) ATE417856T1 (de)
AU (1) AU2003273254B2 (de)
CA (1) CA2492846C (de)
CY (1) CY1108808T1 (de)
DE (1) DE60325377D1 (de)
DK (1) DK1532131T3 (de)
ES (1) ES2316805T3 (de)
PT (1) PT1532131E (de)
SI (1) SI1532131T1 (de)
WO (1) WO2004019879A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8063021B2 (en) 2002-01-17 2011-11-22 Kosan Biosciences Incorporated Ketolide anti-infective compounds
US7407941B2 (en) * 2003-08-26 2008-08-05 Pfizer, Inc. N-desmethyl-N-substituted-11-deoxyerythromycin compounds
GB0327720D0 (en) * 2003-11-28 2003-12-31 Biotica Tech Ltd Erythromycins and process for their preparation
US7211568B2 (en) * 2003-12-18 2007-05-01 Kosan Biosciences Incorporated 9-Desoxoerythromycin compounds as prokinetic agents
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US7582611B2 (en) 2005-05-24 2009-09-01 Pfizer Inc. Motilide compounds
UA87569C2 (ru) * 2005-05-24 2009-07-27 Пфайзер Инк. Соединения для лечения расстройств желудочно-кишечной моторики
BRPI0619556A2 (pt) * 2005-12-08 2011-10-04 Pfizer processo para desmetilação de grupo 3' -dimetil amino de compostos eritromicina
JP5684474B2 (ja) 2006-09-11 2015-03-11 オセラ セラピューティクス, インコーポレイテッド 胃腸の運動障害疾患の治療のためのモチリン受容体の大環状アンタゴニスト
MX2009005977A (es) 2006-12-05 2009-06-17 Pfizer Polimorfos de motilida.
US20080287371A1 (en) * 2007-05-17 2008-11-20 Tranzyme Pharma Inc. Macrocyclic antagonists of the motilin receptor for modulation of the migrating motor complex
CN106138038B (zh) * 2015-04-28 2021-04-20 天津国际生物医药联合研究院 大环内酯类衍生物及其用途
CN106478541A (zh) * 2016-10-17 2017-03-08 南开大学 大环内酯类衍生物及其用途
CN106478542A (zh) * 2016-10-17 2017-03-08 南开大学 一种大环内脂类衍生物盐、其制备方法及用途

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US391594A (en) * 1888-10-23 Arc-extinguisher for electric switches or cut-outs
US4382086A (en) 1982-03-01 1983-05-03 Pfizer Inc. 9-Dihydro-11,12-ketal derivatives of erythromycin A and epi-erythromycin A
US4382085A (en) 1982-03-01 1983-05-03 Pfizer Inc. 4"-Epi erythromycin A and derivatives thereof as useful antibacterial agents
PL136968B1 (en) 1983-02-10 1986-04-30 Tarchominskie Zaklad Farma Process for preparing cyclic 11,12-carbonate of erythromycin a
JPS60218321A (ja) * 1984-04-13 1985-11-01 Satoshi Omura 消化管収縮運動促進剤
EP0184921A3 (de) * 1984-12-08 1986-10-29 Beecham Group Plc Erythromycinderivate
GB8608080D0 (en) 1986-04-02 1986-05-08 Fujisawa Pharmaceutical Co Solid dispersion composition
US4742049A (en) * 1986-06-04 1988-05-03 Abbott Laboratories Semisynthetic erythromycin antibiotics
US4857641A (en) 1987-08-14 1989-08-15 Pfizer Inc. C.12 modified erythromycin A derivatives
IL93936A (en) 1989-03-28 1994-06-24 Abbott Lab History of 9-dioxo-21,9-epoxy - erythromycin, method of preparation History of 11-oxo and 11-hydroxy, and pharmaceutical preparations containing them
US5190871A (en) 1989-06-12 1993-03-02 Eli Lilly And Company Use of the site-specific integrating function of phage φC31
US5824513A (en) 1991-01-17 1998-10-20 Abbott Laboratories Recombinant DNA method for producing erythromycin analogs
US5523418A (en) 1991-04-09 1996-06-04 Abbott Laboratories Macrocyclic lactam prokinetic agents
DE69211845T2 (de) 1991-04-09 1997-01-23 Abbott Lab Macrozyklische laktam-prokinetika
WO1993013780A1 (en) 1992-01-21 1993-07-22 Abbott Laboratories 4''-deoxyerythromycin derivatives
MY113693A (en) 1992-05-26 2002-05-31 Chugai Pharmaceutical Co Ltd Erythromycin derivatives having an enterokinesis stimulating action
US5712146A (en) 1993-09-20 1998-01-27 The Leland Stanford Junior University Recombinant combinatorial genetic library for the production of novel polyketides
US6066721A (en) 1995-07-06 2000-05-23 Stanford University Method to produce novel polyketides
EP1493814A1 (de) 1995-07-06 2005-01-05 The Leland Stanford Junior University Zellfreie Synthese von Polyketiden
US6077943A (en) 1996-03-01 2000-06-20 Takeda Chemical Industries, Ltd. Method of producing erythromycin derivative
WO1997035590A1 (en) * 1996-03-25 1997-10-02 Platt Chris E 10-aza-9-deoxo-11-deoxy-erythromycin a and derivatives combined with sulfisoxazole
US5712253A (en) 1996-06-18 1998-01-27 Abbott Laboratories Macrocyclic 13-membered ring derivatives of erythromycins A and B
US6271255B1 (en) * 1996-07-05 2001-08-07 Biotica Technology Limited Erythromycins and process for their preparation
US5922849A (en) 1996-11-22 1999-07-13 Abbott Laboratories Process for preparation of N-demethyl-4"-deoxy-erthromycins A and B
AU4472897A (en) * 1997-03-10 1998-09-29 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
WO1999021868A1 (fr) 1997-10-29 1999-05-06 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
AU9645998A (en) 1997-10-29 1999-05-17 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
US6084079A (en) 1998-05-15 2000-07-04 Keyes; Robert F. Process for preparing N-demethyl-N-alkyl erythromycin derivatives
WO2000024907A2 (en) * 1998-10-28 2000-05-04 Kosan Biosciences, Inc. Library of novel "unnatural" natural products
EP1124969A2 (de) 1998-10-29 2001-08-22 Kosan Biosciences, Inc. Rekombinante oleandolid polyketid synthase
AU3353500A (en) 1999-01-27 2000-08-18 Kosan Biosciences, Inc. Synthesis of oligoketides
AU775637B2 (en) * 1999-04-16 2004-08-12 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6524841B1 (en) 1999-10-08 2003-02-25 Kosan Biosciences, Inc. Recombinant megalomicin biosynthetic genes and uses thereof
EP1224300B9 (de) 1999-10-27 2007-09-26 Kosan Biosciences, Inc. Heterologe herstellung von polyketiden
CA2399198A1 (en) 2000-02-18 2001-08-23 Christopher Carreras Motilide compounds
JP2005529579A (ja) 2000-05-02 2005-10-06 コーサン バイオサイエンシーズ, インコーポレイテッド ポリケチドの生合成のための過剰産生宿主
US20020094962A1 (en) 2000-12-01 2002-07-18 Gary Ashley Motilide compounds
CA2429709A1 (en) * 2000-12-01 2002-07-04 Gary Ashley Motilide compounds
EP1365726A2 (de) 2001-02-15 2003-12-03 Kosan Biosciences, Inc. Verfahern zur beurteilung der therapeutischen wirksamkeit
WO2003004509A2 (en) * 2001-07-03 2003-01-16 Chiron Corporation C12 modified erythromycin macrolides and ketolides having antibacterial activity
ITMI20021726A1 (it) * 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.

Also Published As

Publication number Publication date
DE60325377D1 (de) 2009-01-29
DK1532131T3 (da) 2009-02-09
SI1532131T1 (sl) 2009-04-30
CY1108808T1 (el) 2014-04-09
EP1532131B1 (de) 2008-12-17
EP1532131A2 (de) 2005-05-25
CA2492846C (en) 2012-09-25
JP4796300B2 (ja) 2011-10-19
CN100363359C (zh) 2008-01-23
KR20050038594A (ko) 2005-04-27
WO2004019879A3 (en) 2004-06-03
ES2316805T3 (es) 2009-04-16
AU2003273254A1 (en) 2004-03-19
WO2004019879A2 (en) 2004-03-11
CA2492846A1 (en) 2004-03-11
KR101051613B1 (ko) 2011-07-25
PT1532131E (pt) 2009-02-18
JP2005537317A (ja) 2005-12-08
US20040138150A1 (en) 2004-07-15
AU2003273254B2 (en) 2008-10-30
CN1665799A (zh) 2005-09-07
EP1532131A4 (de) 2007-05-30
WO2004019879A8 (en) 2004-07-29
US6946482B2 (en) 2005-09-20

Similar Documents

Publication Publication Date Title
CY1108808T1 (el) Ενωσεις μοτιλιδης
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
EA200300717A1 (ru) Гетероциклилиндазольные и -азаиндазольные соединения в качестве 5-гидрокситриптамин-6-лигандов
CO5611065A2 (es) Difluorometiltiazolilcarboxanilidas
YU21401A (sh) Tetrahidropiridoetri
TW200509892A (en) Novel aminobenzophenone compounds
NO20062020L (no) 1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika
NO20055649L (no) Substituert dihydrokinazolin med antiviale egenskaper
TW200510333A (en) Benzimidazole compounds
BR0315644A (pt) Piperazinil e diazapanil benzamidas e benzotioamidas
SE0302139D0 (sv) Novel compounds
TW200630374A (en) Thiazolyldihydroindazoles
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
ATE386742T1 (de) Imidazonaphthyridine
ATE311389T1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
NO20054361D0 (no) Benzensylfonamidderivater, fremgangsmate for fremstilling og anvendelse derav for behandlig av smerte
SE0003476D0 (sv) Compounds
ATE265455T1 (de) Tetrahydropyridoverbindungen
DE50310579D1 (de) Furancarboxamide
DE60316128D1 (de) N-sulfonylurea-apoptosis-förderer
DE60131968D1 (de) PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN
DE50311756D1 (de) Mikrobizide oxathiincarboxamide
CY1105345T1 (el) Φαινυλαλκινια
CY1106711T1 (el) Υποκατεστημενα παραγωγα προπανο-1,3-διαμινης και η φαρμακευτικη χρηση τους

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1532131

Country of ref document: EP